Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FENG
4201
Phoenix New Media
FENG
$17.5M
| $524K | ﹤0.01% |
26,872
-1,004
| -4% | -$23.7K |
|
|
JKS
4202
CALL
JinkoSolar
JKS
$885M
| $523K | ﹤0.01% |
24,100
-25,900
| -52% | -$523K |
|
|
AVP
4203
PUT
DELISTED
Avon Products, Inc.
AVP
| $523K | ﹤0.01% |
134,800
+68,500
| +103% | +$228K |
|
4204
PUT
Ovintiv
OVV
$16.6B
| $521K | ﹤0.01% |
20,280
-3,829
| -16% | -$119K |
|
|
AVX
4205
DELISTED
AVX Corporation
AVX
| $520K | ﹤0.01% |
31,322
+10,583
| +51% | +$174K |
|
4206
PUT
Box
BOX
$4.55B
| $519K | ﹤0.01% |
29,500
-47,800
| -62% | -$915K |
|
4207
Eldorado Gold
EGO
$9.92B
| $519K | ﹤0.01% |
89,265
-15,651
| -15% | -$66K |
|
4208
OneSpan
OSPN
$604M
| $519K | ﹤0.01% |
36,622
+36,607
| +244,047% | +$582K |
|
4209
Viking Therapeutics
VKTX
$3.89B
| $519K | ﹤0.01% |
62,529
+45,264
| +262% | +$387K |
|
|
RDUS
4210
PUT
DELISTED
Radius Health, Inc.
RDUS
| $519K | ﹤0.01% |
21,300
+3,000
| +16% | +$65.6K |
|
4211
PUT
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$20.1M
| $518K | ﹤0.01% |
+4
| New | +$871K |
|
|
ITCI
4212
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $518K | ﹤0.01% |
39,914
+14,258
| +56% | +$183K |
|
|
LCI
4213
DELISTED
Lannett Company, Inc.
LCI
| $517K | ﹤0.01% |
21,317
-5,383
| -20% | -$142K |
|
4214
AXIS Capital
AXS
$7.54B
| $516K | ﹤0.01% |
8,628
-42,423
| -83% | -$2.47M |
|
4215
CALL
WisdomTree Japan Hedged Equity Fund
DXJ
$7.4B
| $516K | ﹤0.01% |
10,600
+500
| +5% | +$24.9K |
|
4216
PUT
Lazard
LAZ
$4.3B
| $516K | ﹤0.01% |
15,000
+12,900
| +614% | +$462K |
|
|
PDCO
4217
CALL
DELISTED
Patterson Companies, Inc.
PDCO
| $515K | ﹤0.01% |
22,500
+19,900
| +765% | +$442K |
|
4218
PUT
WisdomTree
WT
$3.28B
| $514K | ﹤0.01% |
83,300
+60,200
| +261% | +$409K |
|
|
ACOR
4219
DELISTED
Acorda Therapeutics
ACOR
| $513K | ﹤0.01% |
559
+251
| +81% | +$308K |
|
|
CERN
4220
CALL
DELISTED
Cerner Corp
CERN
| $513K | ﹤0.01% |
7,000
-4,600
| -40% | -$310K |
|
4221
CALL
Monro
MNRO
$402M
| $512K | ﹤0.01% |
6,000
-55,900
| -90% | -$4.66M |
|
4222
Impinj
PI
$5.51B
| $512K | ﹤0.01% |
17,864
-63,757
| -78% | -$1.56M |
|
|
KSU
4223
PUT
DELISTED
Kansas City Southern
KSU
| $512K | ﹤0.01% |
4,200
-28,600
| -87% | -$3.42M |
|
4224
PUT
Huntsman Corp
HUN
$1.81B
| $511K | ﹤0.01% |
25,000
+6,800
| +37% | +$143K |
|
4225
Rayonier Advanced Materials
RYAM
$625M
| $511K | ﹤0.01% |
78,664
+43,705
| +125% | +$455K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.